Sara Sherman | Head of Investor Relations |
Liz Barrett | President and Chief Executive Officer |
Mark Schoenberg | Chief Medical Officer |
Jeff Bova | Chief Commercial Officer |
Molly Henderson | Chief Financial Officer |
Ram Selvaraju | H. C. Wainwright |
Derek Archila | Stifel |
Leland Gershell | Oppenheimer |
Eric Joseph | J.P. Morgan |
Matt Kaplan | Ladenburg Thalmann |
Good morning, ladies and gentlemen. Thank you for standing by and welcome to UroGen Pharma's Third Quarter 2020 Financial Results and Business Update Conference Call. It is now my pleasure to turn the call over to Sara Sherman, Head of Investor Relations for UroGen Pharma. Please go ahead.
Thank you, Jonathan.